Heron Therapeutics (HRTX)
2.44 -0.03 (-1.21%) 09:57 ET [NASDAQ]
2.40 x 500 2.41 x 1,200
Realtime by (Cboe BZX)
2.40 x 500 2.41 x 1,200
Realtime 2.42 -0.05 (-2.02%) 09:29 ET
for Mon, Mar 3rd, 2025
Results
download Want to compare other data? Select Fields| Symbol | HRTX | ZTS | TAK | SMMT | UTHR |
| Company | Heron Therapeutics | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Summit Therapeu ADR | United Therapeutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 2.42 | 166.25 | 14.58 | 20.80 | 316.46 |
| High | 2.48 | 169.07 | 14.92 | 21.38 | 320.76 |
| Low | 2.33 | 166.08 | 14.55 | 20.65 | 316.46 |
| Last | 2.44 | 167.54 | 14.89 | 20.53 | 318.76 |
| Change | -0.03 | +0.30 | +0.48 | -0.16 | -1.29 |
| % Change | -1.21% | +0.18% | +3.33% | -0.77% | -0.40% |
| Volume | 457,594 | 131,064 | 339,762 | 240,010 | 13,773 |
| 20-Day Average Volume | 1,980,218 | 3,715,193 | 1,438,435 | 2,392,763 | 534,020 |
| Previous Close | 2.47 | 167.24 | 14.41 | 20.69 | 320.05 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.81 | 166.90 | 13.82 | 20.40 | 352.67 |
| 20-Day Raw Stochastic | 86.21% | 59.68% | 99.42% | 55.02% | 14.96% |
| 20-Day Relative Strength | 67.94% | 50.78% | 71.26% | 52.93% | 33.65% |
| Weighted Alpha | -10.39 | -7.64 | +6.70 | +7.91 | +17.47 |
| Today's Opinion | 40% Buy | 56% Sell | 40% Buy | 96% Buy | 40% Sell |
| Previous Opinion | 40% Buy | 56% Sell | 40% Buy | 96% Buy | 40% Sell |
| Last Month's Opinion | 24% Sell | 40% Sell | 24% Sell | 72% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +32.77% since 02/24/25 | +1.68% since 02/24/25 | +5.89% since 02/24/25 | +12.87% since 02/24/25 | -11.01% since 02/24/25 |
| Low | 1.65 on 02/25/25 | 163.35 on 02/25/25 | 14.27 on 02/27/25 | 17.70 on 02/25/25 | 307.38 on 02/26/25 |
| High | 2.47 on 02/28/25 | 169.00 on 02/26/25 | 14.92 on 03/03/25 | 21.30 on 03/03/25 | 364.98 on 02/25/25 |
| 1-Month | |||||
| %Chg | +39.05% since 02/03/25 | -2.24% since 02/03/25 | +12.53% since 02/03/25 | +6.43% since 02/03/25 | -10.10% since 02/03/25 |
| Low | 1.60 on 02/12/25 | 154.32 on 02/18/25 | 13.19 on 02/12/25 | 17.70 on 02/25/25 | 307.38 on 02/26/25 |
| High | 2.47 on 02/28/25 | 177.40 on 02/06/25 | 14.92 on 03/03/25 | 24.18 on 02/21/25 | 383.51 on 02/19/25 |
| 3-Month | |||||
| %Chg | +99.15% since 12/03/24 | -5.00% since 12/03/24 | +7.11% since 12/03/24 | +19.67% since 12/03/24 | -13.56% since 12/03/24 |
| Low | 1.46 on 01/14/25 | 154.32 on 02/18/25 | 12.80 on 01/23/25 | 16.46 on 01/14/25 | 307.38 on 02/26/25 |
| High | 2.47 on 02/28/25 | 181.85 on 12/13/24 | 14.92 on 03/03/25 | 25.00 on 01/24/25 | 383.51 on 02/19/25 |
| 6-Month | |||||
| %Chg | +35.84% since 09/03/24 | -8.43% since 09/03/24 | -0.07% since 09/03/24 | +68.77% since 09/03/24 | -9.54% since 09/03/24 |
| Low | 1.04 on 11/12/24 | 154.32 on 02/18/25 | 12.80 on 01/23/25 | 11.76 on 09/05/24 | 307.38 on 02/26/25 |
| High | 2.47 on 02/28/25 | 200.33 on 09/19/24 | 14.99 on 09/04/24 | 33.89 on 09/16/24 | 417.82 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 375,675 | 74,888,736 | 45,850,820 | 15,262,600 | 14,374,082 |
| Shares Outstanding, K | 152,095 | 447,792 | 3,181,875 | 737,680 | 44,912 |
| Annual Sales | 127,040,000 | 9,256,000,000 | 29,419,960,000 | 0 | 2,327,500,000 |
| Annual Net Income | -110,560,000 | 2,486,000,000 | 994,060,000 | -614,930,000 | 984,800,000 |
| Last Quarter Sales | 32,810,000 | 2,317,000,000 | 7,511,170,000 | 0 | 748,900,000 |
| Last Quarter Net Income | -4,850,000 | 581,000,000 | 156,180,000 | -56,250,000 | 309,100,000 |
| 60-Month Beta | 1.60 | 0.90 | 0.51 | -0.88 | 0.57 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.03 on 11/12/24 | 1.40 on 02/13/25 | 0.42 on 01/30/25 | -0.08 on 02/24/25 | 6.19 on 02/26/25 |
| Latest Earnings Date | 02/27/25 | 02/13/25 | 02/06/25 | 02/24/25 | 02/26/25 |
| Most Recent Dividend | N/A | 0.500 on 01/21/25 | 0.267 on 09/30/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/21/25 | 09/30/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 27.87 | 10.10 | 0.00 | 13.16 |